Indian Type 2 Medication Could be Studied by Mayo Clinic

How did one type 2 go from 20 units of insulin per day to none, and no blood sugar level above 185? He took Cogent DB, an Indian type 2 medication made from several herbs, which the Mayo Clinic is reported to be interested in testing.

Without it, Krishnakumar Moorthy says he would be “certainly on insulin-and probably crippled.”

A story in the Indian news magazine The Week tells the story of Moorthy and how Cogent DB came to the 2 million people with diabetes now using it in India.

After helping his father through severe diabetic neuropathy, P.N.E. Balaram watched him die.

After his death, this Indian entrepreneur got a recipe from a friend for an Ayurvedic diabetes remedy. Balaram had it translated from its original Sanskrit, collected the herbal ingredients and made the concoction, which he gave to a friend’s father who has diabetes. One week later, the friend asked him for more. The remedy had lowered his blood sugars, something his other medicine had not done.

Getting Scientific Proof

He gave it to others, with the same success, but Balaram knew these stories would not sell a product. He needed scientific proof.

He took it to the Amala Cancer Research Centre in the Kerala State of India. First researchers studied rats with alloxan-induced diabetes, and found that Cogent DB reduced their blood sugar levels and improved their liver and kidney functioning.

Some criticize the alloxan method of testing rats. One Indian endocrinologist says that claiming liver and kidney healing is far-fetched, as the Cogent DB could just be reversing the damage that alloxan causes.

Studies done in humans, however, did confirm the blood-sugar-lowering effects. According to Balaram and his company, Cybele Herbal Laboratories, studies performed at the Amala center show that Cogent DB lowered the fasting and postmeal blood sugars in nearly all type 2 subjects.

Word Gets Around

The Week says that the Mayo Clinic of Rochester, Minnesota, wants to study Cogent DB. Mayo’s head of research, Dr. Sreekumaran Nair, is reportedly interested in confirming the success of Cogent DB with “careful and well-controlled trials.”

Nair did not answer DIABETES HEALTH’s calls for confirmation of this study’s possibility, but Balaram says, “Dr. Nair, his Mayo Clinic team and their associates in Trivandrum, India, are testing Cogent DB.”

How does it work in the body to lower blood sugar? It seems that nobody knows, not even Balaram. Sreekumaran isn’t sure. Until larger tests are performed, this herbal preparation has only time and anecdotes on its side, as this is the case with many ancient formulas.

“Cogent DB is a unique formula of some of the most powerful time-tested antidiabetic herbs,” says Balaram. Clinical testing, he adds, “is only a process of validation and not inventing something new.”

Leave a Reply

Your email address will not be published.